SCHEMBL5225090

SCHEMBL5225090

CCn1ccc2c(N3CCCC3=O)cc(C(=O)O)cc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 5/20 0.53
CTSD P07339 4/20 0.53
BACE2 Q9Y5Z0 4/20 0.53
ALDH1A1 P00352 3/20 0.44
CYP2C9 P11712 4/20 0.43
HPGD P15428 3/20 0.43
CYP3A4 P08684 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
GAA P10253 1/20 0.40
USP2 O75604 2/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
HSD17B10 Q99714 2/20 0.37
KDM4E B2RXH2 1/20 0.37
TSHR P16473 1/20 0.37
RARA P10276 1/20 0.37
RARB P10826 1/20 0.37
RARG P13631 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5222810 0.90 BACE1 (0.51) BACE1CTSDBACE2ALDH1A1CYP2C9
SCHEMBL5223578 0.89 BACE1 (0.45) BACE1CTSDBACE2ALDH1A1CYP2C9
SCHEMBL5219794 0.88 BACE1 (0.44) BACE1CTSDBACE2ALDH1A1CYP2C9
SCHEMBL5219489 0.84 ALDH1A1 (0.47) BACE1CTSDBACE2ALDH1A1CYP2C9
SCHEMBL5216936 0.79 BACE1 (0.44) BACE1CTSDBACE2ALDH1A1CYP2C9
SCHEMBL5389542 0.79 BACE1 (0.42) BACE1CTSDBACE2ALDH1A1CYP2C9
SCHEMBL5389115 0.79 BACE1 (0.43) BACE1CTSDBACE2ALDH1A1CYP2C9
SCHEMBL5219279 0.78 CTSD (0.51) BACE1CTSDBACE2ALDH1A1CYP2C9
SCHEMBL5220770 0.78 BACE1 (0.52) BACE1CTSDBACE2ALDH1A1CYP2C9
SCHEMBL308351 0.77 NPC1 (0.44) ALDH1A1HPGDGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed